Plasma Ceramides Target Skeletal Muscle in Type 2 Diabetes
- John P. Kirwan⇓
- Metabolic Translational Research Center, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio; the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio and
- Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
- Corresponding author: John P. Kirwan, kirwanj{at}ccf.org.
Article Information
vol. 62 no. 2 352-354
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print January 24, 2013.
Copyright & Usage
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- John P. Kirwan⇓
- Metabolic Translational Research Center, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio; the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio
- Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio and
- Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
- Corresponding author: John P. Kirwan, kirwanj{at}ccf.org.
Statistics from Altmetric.com
Article usage
In this Issue
February 2013, 62(2)
